TimothySilleckBaileyMD

Endocrinology • Escondido, CA

Diabetes, Lipid Metabolism, Thyroid

Physician

Join to view full profile

Dr. Bailey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bailey's full profile

Already have an account?

Office
625 Citracado Pkwy
Ste 108
Escondido, CA 92025
Phone+1 760-743-1431

Fax+1 760-743-6455

Education & Training

SUNY Downstate Health Sciences UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1990
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1984 - 1987
Icahn School of Medicine at Mount SinaiClass of 1984

Certifications & Licensure

CA State Medical License 1987 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Overnight Closed Loop Study in U.S. Start of enrollment: 2013 Jun 01
Completed
Not Applicable
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data Start of enrollment: 2013 Nov 26
Completed
Not Applicable
In Clinic Evaluation of the PLGM Feature Start of enrollment: 2014 Oct 01
Completed
Not Applicable
Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes Start of enrollment: 2015 Jun 01
Completed
Not Applicable
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
Completed
Not Applicable
An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2015 Oct 20
Completed
Phase 3
Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes Start of enrollment: 2016 Apr 18
Completed
Not Applicable
Assessment of Mealtime Bolus Insulin Behavior Start of enrollment: 2017 Dec 11
Completed
Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics Start of enrollment: 2020 Jul 15
Completed
Not Applicable
FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study Start of enrollment: 2020 Jul 10
Completed
Clinical Investigation of K'Watch - Lab & Home Study Start of enrollment: 2021 Nov 15
Recruiting
Roles: Contact
Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features Start of enrollment: 2021 Oct 20
Recruiting
Not Applicable
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Evaluation of Accuracy and Safety of the 365-Day Implantable Eversense Continuous Glucose Monitoring System: The ENHANCE Study.
Timothy S Bailey, David R Liljenquist, Douglas S Denham, Ronald L Brazg, Sorin Ioacara
Diabetes Technology & Therapeutics. 2025-01-27
1 citations
The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors.
David C Klonoff, Guido Freckmann, Stefan Pleus, Boris P Kovatchev, David Kerr
Journal of Diabetes Science and Technology. 2024-11-01
Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal-bolus insulin regimens in treat-to-target trials: A narrativ...
David Russell-Jones, Timothy S Bailey, Wendy Lane, Chantal Mathieu, Ulrik Pedersen-Bjergaard
Diabetic Medicine. 2024-07-01

Press Mentions

Senseonics Announces First Paediatric Insertion for Eversense in TrialApril 19th, 2023
Medtronic’s Guardian Connect Continuous Glucometer with Predictive Capabilities Approved by FDAMarch 12th, 2018
FDA Clears Medtronic's Smartphone-Connected CGM for MDI UsersMarch 12th, 2018
Join now to see all

TimothySilleckBaileyMD

Dr. Bailey is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.